233 related articles for article (PubMed ID: 17624703)
1. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
3. Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB.
Di L; Kerns EH; Bezar IF; Petusky SL; Huang Y
J Pharm Sci; 2009 Jun; 98(6):1980-91. PubMed ID: 18837012
[TBL] [Abstract][Full Text] [Related]
4. A PAMPA study of the permeability-enhancing effect of new ceramide analogues.
Sinkó B; Kökösi J; Avdeef A; Takács-Novák K
Chem Biodivers; 2009 Nov; 6(11):1867-74. PubMed ID: 19937821
[TBL] [Abstract][Full Text] [Related]
5. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
6. Generic fast gradient liquid chromatography/tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery.
Chu I; Liu F; Soares A; Kumari P; Nomeir AA
Rapid Commun Mass Spectrom; 2002; 16(15):1501-5. PubMed ID: 12125028
[TBL] [Abstract][Full Text] [Related]
7. Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.
Yoon CH; Kim SJ; Shin BS; Lee KC; Yoo SD
J Biomol Screen; 2006 Feb; 11(1):13-20. PubMed ID: 16314407
[TBL] [Abstract][Full Text] [Related]
8. A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis.
Balimane PV; Pace E; Chong S; Zhu M; Jemal M; Pelt CK
J Pharm Biomed Anal; 2005 Sep; 39(1-2):8-16. PubMed ID: 15978768
[TBL] [Abstract][Full Text] [Related]
9. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
10. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
[TBL] [Abstract][Full Text] [Related]
11. Methods to assess drug permeability across the blood-brain barrier.
Nicolazzo JA; Charman SA; Charman WN
J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
[TBL] [Abstract][Full Text] [Related]
12. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
Teixidó M; Zurita E; Malakoutikhah M; Tarragó T; Giralt E
J Am Chem Soc; 2007 Sep; 129(38):11802-13. PubMed ID: 17764181
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
[TBL] [Abstract][Full Text] [Related]
14. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
15. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
Flaten GE; Dhanikula AB; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
[TBL] [Abstract][Full Text] [Related]
16. Skin-PAMPA: a new method for fast prediction of skin penetration.
Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
[TBL] [Abstract][Full Text] [Related]
17. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
Vucicevic J; Nikolic K; Dobričić V; Agbaba D
Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
[TBL] [Abstract][Full Text] [Related]
18. Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.
Malakoutikhah M; Teixidó M; Giralt E
J Med Chem; 2008 Aug; 51(16):4881-9. PubMed ID: 18666771
[TBL] [Abstract][Full Text] [Related]
19. PAMPA study of the temperature effect on permeability.
Vizserálek G; Balogh T; Takács-Novák K; Sinkó B
Eur J Pharm Sci; 2014 Mar; 53():45-9. PubMed ID: 24361474
[TBL] [Abstract][Full Text] [Related]
20. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
Vastag M; Keseru GM
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
